DALLAS — Abeona Therapeutics Inc. (ABEO) on Monday reported a loss of $16.4 million in its fourth quarter.
The Dallas-based company said it had a loss of 30 cents per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
For the year, the company reported that its loss widened to $76.3 million, or $1.51 per share.